Jarosław Kępski/LinkedIn
Dec 13, 2025, 08:22
Jarosław Kępski: Managing Anticoagulation in Oncology Patients With Thrombocytopenia
Jarosław Kępski, Cardiologist and member of the ESC Council of Cardio-Oncology (COOL) Committee, reposted from Davood KHoda-Amorzideh on LinkedIn:
”Thrombocytopenia presents a particular challenge in oncology, especially when patients require anticoagulation. We invite you to read our analysis of current recommendations.”
Quoting Davood KHoda-Amorzideh‘s post:
”Anticoagulant – therapy in patients with cancer and thrombocytopenia.”
Title: Anticoagulant therapy in patients with cancer and thrombocytopenia
Author: Sebastian Szmit, Jarosław Kępski, Ewa Lech-Marańda, Dariusz M. Kowalski, Maciej Krzakowski, Magdalena Zaborowska-Szmit
Read the full article here.
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events